IS PREVENTIVE MASTECTOMY IN CASE OF HEREDITARY BREAST CANCER NEEDED OR NOT?
There has been some controversy recently related to a clinical study in The Netherlands comparing overall survival rates between women with BrCa1 and BrCa2 mutations who underwent preventive mastectomy and those who opted for regular screening. The results seem to suggest that for BrCa2 mutations, no clinically relevant differences exist. However, as with all clinical studies, the conclusions need to be put in context.